User:Ana-Teresa Maia: Difference between revisions
No edit summary |
No edit summary |
||
(6 intermediate revisions by the same user not shown) | |||
Line 4: | Line 4: | ||
*<b> Ana-Teresa Maia | *<b> Ana-Teresa Maia | ||
Group Leader of Cancer Functional Genomics Group <br> | Group Leader of Cancer Functional Genomics Group <br> | ||
Carrer Integration Grant Holder - Marie Curie <br> | |||
Assistant Professor </b><br> | Assistant Professor </b><br> | ||
IBB/CBME Laboratório Associado <br> | IBB/CBME Laboratório Associado <br> | ||
Line 16: | Line 17: | ||
* 1999, MS, Imperial College of Science, Technology and Medicine, London, U.K. | * 1999, MS, Imperial College of Science, Technology and Medicine, London, U.K. | ||
* 1997, BS, Faculty of Science and Technology, New University of Lisbon, Monte da Caparica, Portugal | * 1997, BS, Faculty of Science and Technology, New University of Lisbon, Monte da Caparica, Portugal | ||
==Research Interests== | |||
2012 - present : Assistant Professor, University of Algarve | |||
Program in Regenerative Medicine, Department of Biomedical Sciences and Medicine | |||
Maternity Leave: March 2013- September 2013 | |||
2012 - present : Group Leader, Associate Laboratory IBB/CBME | |||
Cancer Functional Genomics Group | |||
10/2008 – 12/2011 : Senior Research Associate, University of Cambridge | |||
Department of Oncology at Cambridge Research Institute-CRUK | |||
Supervisor: Professor Sir Bruce Ponder | |||
10/2006 - 9/2008 : Research Associate, University of Cambridge | |||
Department of Oncology at Cambridge Research Institute-CRUK | |||
Supervisor: Professor Sir Bruce Ponder | |||
9/2003 - 9/2006 : Research Associate, University of Cambridge | |||
Department of Oncology at Hutchison/MRC Institute | |||
Supervisors: Professors Sir Bruce Ponder and Carlos Caldas | |||
2/2001 : Visiting Student to Professor Andrea Biondi's group | |||
Clinica Pediatrica dell’Università degli Studi di | |||
Milano-Bicocca, Ospedale San Gerardo di Monza | |||
9/1999 - 8/2003 : PhD Student, Institute of Cancer Research | |||
Leukaemia Research Fund Centre | |||
Supervisor: Professor Mel Greaves | |||
9/1998 - 8/1999 : MSc Student, Imperial College of Science, Technology and Medicine | |||
Supervisor: Professor Mel Greaves | |||
9/1996 - 8/1998 : Researcher in training, New University of Lisbon | |||
Department of Genetics, Faculty of Medical Sciences | |||
==Research Interests== | ==Research Interests== | ||
Line 36: | Line 73: | ||
</biblio> | </biblio> | ||
==Funding== | ==Funding== | ||
Line 58: | Line 86: | ||
* PBL classes to 1st and 2nd years | * PBL classes to 1st and 2nd years | ||
* Seminars in Basic Sciences | * Seminars in Basic Sciences | ||
* Coordinator of Student Chosen Module for 2 year (5 weeks training in laboratory or clinical work)) | |||
Masters of Science in Oncobiology - Molecular Mechanisms of Cancer | Masters of Science in Oncobiology - Molecular Mechanisms of Cancer |
Latest revision as of 09:06, 27 October 2014
Contact Info
- Ana-Teresa Maia
Group Leader of Cancer Functional Genomics Group
Carrer Integration Grant Holder - Marie Curie
Assistant Professor
IBB/CBME Laboratório Associado
Department of Biomedical Sciences and Medicine
University of Algarve
Gambelas, Faro, Portugal
Email me through OpenWetWare
Education
- 2003, PhD, Institute of Cancer Research, London, U.K.
- 1999, MS, Imperial College of Science, Technology and Medicine, London, U.K.
- 1997, BS, Faculty of Science and Technology, New University of Lisbon, Monte da Caparica, Portugal
Research Interests
2012 - present : Assistant Professor, University of Algarve Program in Regenerative Medicine, Department of Biomedical Sciences and Medicine Maternity Leave: March 2013- September 2013
2012 - present : Group Leader, Associate Laboratory IBB/CBME Cancer Functional Genomics Group
10/2008 – 12/2011 : Senior Research Associate, University of Cambridge Department of Oncology at Cambridge Research Institute-CRUK Supervisor: Professor Sir Bruce Ponder
10/2006 - 9/2008 : Research Associate, University of Cambridge Department of Oncology at Cambridge Research Institute-CRUK Supervisor: Professor Sir Bruce Ponder
9/2003 - 9/2006 : Research Associate, University of Cambridge Department of Oncology at Hutchison/MRC Institute Supervisors: Professors Sir Bruce Ponder and Carlos Caldas
2/2001 : Visiting Student to Professor Andrea Biondi's group Clinica Pediatrica dell’Università degli Studi di Milano-Bicocca, Ospedale San Gerardo di Monza
9/1999 - 8/2003 : PhD Student, Institute of Cancer Research Leukaemia Research Fund Centre Supervisor: Professor Mel Greaves
9/1998 - 8/1999 : MSc Student, Imperial College of Science, Technology and Medicine Supervisor: Professor Mel Greaves
9/1996 - 8/1998 : Researcher in training, New University of Lisbon Department of Genetics, Faculty of Medical Sciences
Research Interests
I am interested in studying allelic imbalance in gene expression, a common feature of our genome. Due to regulatory polymorphisms, which can occur both in cis- and in trans-, a large number of our genes are preferentially expressed from one allele. This unequal expression can contribute to susceptibility to common diseases. My main aim is to try to use this concept to develop a new method to study predisposition to breast cancer. Additionally, I am investigating the role that this imbalance can play in tumour biology, namely in the effect of mutations and treatment response.
Publications
For all publications
http://publicationslist.org/ana-teresa.maia
Selected Papers
-
Curtis CN et al. (2012) Nature:486(7403):346-52 pmid= 22522925
-
Maia AT et al. (2012) Breast Cancer Research:R63pmid= 22513257
-
Maia AT et al. (2009) Breast Cancer Research:R88 pmid= 20003265
-
Meyer KM, Maia AT et al. (2008) PLoS Biology:6(5):e108 pmid= 18462018
-
Udler M, Maia AT et al. (2007) Journal of Clinical Oncology:25(21):3015-23 pmid= 17634480
Funding
- 2013 - 2015 “Cis-regulation of somatic mutations in breast and ovarian cancers”; PTDC/BIM-ONC/1338/2012; Foundation for Science and Technology, Portugal
- 2012 - 2016 Marie Curie Integration Grant, GenCar - Genetic Control of Gene Expression in Cancer Risk, FP7-MC-CIG, European Union
- 2009 – 2010 Breast Cancer Research Foundation Grant, U.S.A., Differential Allelic Expression Analysis of Susceptibility Loci in Breast Cancer, USA
- 2008 – 2009 Breast Cancer Research Foundation Grant, U.S.A., Differential Allelic Expression Analysis of Susceptibility Loci in Breast Cancer, USA
Teaching
Integrated Masters in Medicine
* PBL classes to 1st and 2nd years * Seminars in Basic Sciences * Coordinator of Student Chosen Module for 2 year (5 weeks training in laboratory or clinical work))
Masters of Science in Oncobiology - Molecular Mechanisms of Cancer
Vice-Director * Oncogenetics and Oncogenomics * Genetic Toxicology * Clinical Oncology
Masters of Science in BIomedical Sciences
* Computational Biology
Undergraduate Degree in BIomedical Sciences
* Human Genetics
Useful links
- CBME http://www.cbme.ualg.pt/
- DCBM/UAlg http://dcbm.ualg.pt/home/
- MSc in Oncobiology http://dcbm.ualg.pt/home/pt/curso/1716